Blood Diagnostics Startup Sight Raises $27.8M For System That Delivers Results In Minutes | News Brief
16 Feb 2019 6:30 PM GMT
Sight Diagnostics developed the OLO, an AI-driven system that allows for blood test results in minutes, and with just a quick finger-prick.
- Sight Diagnostics, an Israel-founded company that develops lab-grade blood testing systems, announced the completion of a $27.8 million Series C funding round led by Longliv Ventures, with participation from healthcare philanthropist Jack Nicklaus II, healthcare impact investor Steven Esrick, and existing investors OurCrowd, Go Capital, and New Alliance Capital.
- Sight Diagnostics plans to use the funds for technological and commercial expansion of diagnostics system OLO as well as regulatory efforts in the US and R&D to expand its menu of diagnostic tests.
- Sight Diagnostics now says its technology offers Complete Blood Counts (CBCs) – the most prevalent blood test in the world, and plans to develop further applications.
- The OLO system launched in Europe in the summer of 2018 after a clinical trial, which led to OLO’s CE Mark registration and approval for commercial sale in the EU.
Next Story
